Multiple targets involved in glucose metabolism and insulin sensitivity

“Multiple targets involved in glucose metabolism and insulin sensitivity" is not a single molecular entity but refers collectively to various proteins and regulatory molecules that control blood sugar levels and tissue responses to insulin. These include enzymes such as acetyl-CoA carboxylase (ACC), diacylglycerol acyltransferase 2 (DGAT2), nuclear receptors like peroxisome proliferator–activated receptors (PPARs), growth factors such as myostatin (MSTN), as well as regulatory microRNAs including miR‑26a, miR‑4428, and miR‑185–5p. Each plays distinct roles in processes like hepatic gluconeogenesis suppression by insulin, regulation of fatty acid synthesis, inflammation-mediated impairment of signaling, or direct modulation at the gene expression level. Drugs targeting these molecules aim to restore normal metabolic function in diseases such as type 2 diabetes mellitus, obesity-related disorders, and non-alcoholic steatohepatitis. Because this entry does not refer to one canonical molecule/receptor but rather an entire network/pathway comprising many validated therapeutic targets—each with its own nomenclature—this is considered an incorrect/non-canonical "target" entry under standard biomedical conventions.

Other names

Multiple targets involved in glucose metabolism and insulin sensitivityGlucose metabolism and insulin sensitivity pathways (informal)

Mechanisms depend on the specific target but include: Inhibition of fatty acid synthesis enzymes to improve insulin sensitivity and reduce hepatic steatosis; Activation or modulation of nuclear receptors to enhance glucose uptake or lipid oxidation; Modulation of microRNAs that regulate gene expression in metabolic pathways